NCT07190183

Brief Summary

Food intolerance (FI) is an adverse reaction to food caused by non-immune mechanisms, mainly related to digestive enzyme deficiencies (e.g. lactase deficiency), metabolic abnormalities (e.g. impaired absorption of fructose) or toxicity of food components (e.g. histamine). Unlike immune-mediated food allergy, FI symptoms are usually delayed (hours to days after ingestion) and mild, but are difficult to diagnose and manage clinically due to the complexity and variety of mechanisms that affect approximately 20% of the world's population.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
118mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2025Dec 2035

Study Start

First participant enrolled

January 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 17, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2035

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2035

Last Updated

September 24, 2025

Status Verified

January 1, 2025

Enrollment Period

10.1 years

First QC Date

September 17, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

washed microbiota transplantationfood intolerancefecal microbiota transplantationgut microbiota

Outcome Measures

Primary Outcomes (2)

  • change of weight and height

    Weight and height will be combined to report BMI in kg/m\^2.

    baseline, 4 weeks, 12 weeks post transplantation

  • change of the Gastrointestinal Symptom Rating Scale(GSRS)

    GSRS is a 13-item test to make a comprehensive assessment of common gastrointestinal symptom and each item receives a value from 0 to 3, with higher value indicating worse gastrointestinal condition.

    baseline, 4 weeks, 12 weeks post transplantation

Secondary Outcomes (3)

  • change of insulin-like growth factor I(IGF-I),intestinal barrier function and immunoglobulin

    baseline, 12 weeks post transplantation

  • the difference of the gut microbiota composition before and after washed microbiota transplantation

    baseline, 12 weeks post transplantation

  • the incidence of treatment-related adverse events (AE) assessed by CTCAE, Version 5.0

    12 weeks post transplantation

Study Arms (2)

The FI undergoing washed microbiota transplantation

patients undergoing washed microbiota transplantation who were diagnosed as food intolerance according to laboratory examination

Procedure: washed microbiota transplantation

The FI not undergoing washed microbiota transplantation

The FI did not undergo washed microbiota transplantation

Interventions

The prepared microbiota suspension was infused into the patients' gut.

Also known as: fecal microbiota transplantation
The FI undergoing washed microbiota transplantation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with food intolerance receiving WMT will be enrolled.

You may qualify if:

  • Food intolerance occurs through laboratory examination of at least two main foods
  • Underwent washed microbiota transplantation.

You may not qualify if:

  • Expected survival time \<3 months;
  • Women who are pregnant or breastfeeding;
  • Other patients deemed not suitable for enrollment by the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

faeces

MeSH Terms

Conditions

Food Intolerance

Interventions

Fecal Microbiota Transplantation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Biological TherapyTherapeutics

Study Officials

  • Faming Zhang, PhD

    The Second Hospital of Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professsor, Gastroenterology

Study Record Dates

First Submitted

September 17, 2025

First Posted

September 24, 2025

Study Start

January 1, 2025

Primary Completion (Estimated)

February 10, 2035

Study Completion (Estimated)

December 31, 2035

Last Updated

September 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations